SAN DIEGO, June 13 /PRNewswire/ -- Diversa Corporation (Nasdaq: DVSA - news) today announced the successful development and automation of its GigaMatrix(TM) platform, an ultra high-throughput screening platform that is the first system known to utilize plates with a 100,000-well density. Exponentially more efficient than standard 96-, 384-, or 1536-well screening systems, the GigaMatrix platform combines automated robotics and a 100,000-well format contained in the 3.3`` x 5'' footprint of a standard plate.
The GigaMatrix platform permits rapid screening of genes and gene pathways, and is expected to increase the productivity of Diversa's discovery programs for products such as novel enzymes and small molecule drugs. The screening platform is also being adapted to Diversa's antibody and protein therapeutic programs, which require rapid screening of the large numbers of antibody and protein variants created by Diversa's evolution technologies.
The GigaMatrix technology, employing over 1,000 wells per square centimeter, greatly expands the amount of molecular diversity that can be screened to discover products. The platform also dramatically reduces equipment and operator time through massively parallel dispensing and reading of biological samples. The GigaMatrix plates, with wells each about the diameter of a human hair, are reusable and require only miniscule volumes of reagents, making them highly cost effective. For additional information on the GigaMatrix technology, including images and video of this novel screening system, please visit Diversa's website at diversa.com. |
